Total Cash (mrq): 24.99M
Total Cash Per Share (mrq): 0.71
Total Debt (mrq): 0.00
Total Debt/Equity (mrq): N/A
Current Ratio (mrq): 12.28
Book Value Per Share (mrq): 0.60
Avg Vol (3 month)3: 114,581
Avg Vol (10 day)3: 104,038
Shares Outstanding5: 35.29M
Float: 33.47M
% Held by Insiders1: 10.04%
% Held by Institutions1: 18.20%
Shares Short (as of May 31, 2012)3: 482.40K
Short Ratio (as of May 31, 2012)3: 3.40
Short % of Float (as of May 31, 2012)3: 1.50%
Shares Short (prior month)3: 485.54K
Total Cash Per Share (mrq): 0.71
Total Debt (mrq): 0.00
Total Debt/Equity (mrq): N/A
Current Ratio (mrq): 12.28
Book Value Per Share (mrq): 0.60
Avg Vol (3 month)3: 114,581
Avg Vol (10 day)3: 104,038
Shares Outstanding5: 35.29M
Float: 33.47M
% Held by Insiders1: 10.04%
% Held by Institutions1: 18.20%
Shares Short (as of May 31, 2012)3: 482.40K
Short Ratio (as of May 31, 2012)3: 3.40
Short % of Float (as of May 31, 2012)3: 1.50%
Shares Short (prior month)3: 485.54K
Recent CGEN News
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 05/18/2026 08:02:35 PM
- Compugen surges after revenue tops forecasts despite quarterly loss miss (CGEN) • IH Market News • 05/18/2026 12:35:18 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/18/2026 11:00:20 AM
- Compugen Reports First Quarter 2026 Results • PR Newswire (US) • 05/18/2026 11:00:00 AM
- Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum • PR Newswire (US) • 05/12/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 08:03:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 08:02:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/27/2026 10:52:43 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/27/2026 10:40:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/15/2026 08:10:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/15/2026 08:07:11 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 04/15/2026 08:03:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/15/2026 10:38:12 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/15/2026 10:16:38 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/13/2026 11:28:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 08:05:10 PM
- Compugen to Participate in 25th Annual Needham Virtual Healthcare Conference • PR Newswire (US) • 04/09/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 11:31:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 11:29:40 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/02/2026 02:06:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/30/2026 10:04:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/26/2026 02:42:06 PM

